ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35089
0,01%
Bitcoin
66.196,65
-0,66%
Brent Oil
82,01
-0,14%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Athenex Inc (ATNX)

  7. Athenex Inc (ATNX) Notícias

ATNX

Athenex (ATNX)

Athenex Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ATNX
DataHoraFonteTítuloCódigoCompanhia
23/05/202309:04Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ATNXAthenex Inc
22/05/202317:16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ATNXAthenex Inc
14/05/202312:15GlobeNewswire Inc.Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales ProcessNASDAQ:ATNXAthenex Inc
08/05/202317:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ATNXAthenex Inc
01/05/202314:00PR Newswire (US)Quantum Leap Healthcare Collaborative Announces Result of Oral Paclitaxel in Combination with a PD-1 and Carboplatin from I-SPY2 TRIAL at ASCONASDAQ:ATNXAthenex Inc
28/04/202309:11Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ATNXAthenex Inc
20/03/202315:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ATNXAthenex Inc
20/03/202309:00GlobeNewswire Inc.Athenex Provides Fourth Quarter and Full Year 2022 Financial Results and Business UpdateNASDAQ:ATNXAthenex Inc
14/02/202318:25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ATNXAthenex Inc
14/02/202310:00GlobeNewswire Inc.Athenex Announces a Reverse Stock SplitNASDAQ:ATNXAthenex Inc
02/02/202319:02Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ATNXAthenex Inc
03/01/202310:00GlobeNewswire Inc.Athenex Announces MHRA Decision on Oral PaclitaxelNASDAQ:ATNXAthenex Inc
20/12/202210:15GlobeNewswire Inc.Athenex Announces Quantum Leap Healthcare Collaborative Reports Positive Trial Result of I-SPY2 Trial for Oral Paclitaxel in Combination with PD-1 and Carboplatin in Neoadjuvant Breast CancerNASDAQ:ATNXAthenex Inc
16/12/202210:00GlobeNewswire Inc.Athenex Exits 503B Sterile Compounding BusinessNASDAQ:ATNXAthenex Inc
09/12/202218:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ATNXAthenex Inc
22/11/202212:30GlobeNewswire Inc.Athenex Announces Positive Results of Special Stockholder MeetingNASDAQ:ATNXAthenex Inc
21/11/202210:00GlobeNewswire Inc.Athenex Announces Closing of the Sale of its China API BusinessNASDAQ:ATNXAthenex Inc
07/11/202200:26TipRanksSVB Securities Sticks to Their Hold Rating for Athenex (ATNX)NASDAQ:ATNXAthenex Inc
03/11/202211:56Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ATNXAthenex Inc
03/11/202208:05GlobeNewswire Inc.Athenex Announces Receipt of Positive Nasdaq Listing DeterminationNASDAQ:ATNXAthenex Inc
03/11/202208:00GlobeNewswire Inc.Athenex Provides Third Quarter 2022 Financial Results and Business UpdateNASDAQ:ATNXAthenex Inc
11/10/202210:15GlobeNewswire Inc.Athenex Files Definitive Proxy Statement for Special Stockholder MeetingNASDAQ:ATNXAthenex Inc
11/10/202209:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ATNXAthenex Inc
12/08/202216:56Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ATNXAthenex Inc
11/08/202205:21GlobeNewswire Inc.Athenex, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and WarrantsNASDAQ:ATNXAthenex Inc
10/08/202217:01GlobeNewswire Inc.Athenex, Inc. Announces Proposed Underwritten Public Offering of Common Stock and WarrantsNASDAQ:ATNXAthenex Inc
05/08/202205:33TipRanksHere’s Why Athenex Shares Surged 70%NASDAQ:ATNXAthenex Inc
01/08/202200:31TipRanksSVB Securities Reiterates a Hold Rating on Athenex (ATNX)NASDAQ:ATNXAthenex Inc
28/07/202208:00GlobeNewswire Inc.Athenex Provides Second Quarter 2022 Financial Results and Business UpdateNASDAQ:ATNXAthenex Inc
25/07/202211:00GlobeNewswire Inc.Athenex Announces Publication of Data from Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer in the Journal of Clinical OncologyNASDAQ:ATNXAthenex Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ATNX

Seu Histórico Recente

BOV
HBOR3
HELBOR ON
BOV
PRIO3
PETRORIO ON
BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados